Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Daniela Mancusi"'
Autor:
Nadia Galizzi, Laura Galli, Andrea Poli, Nicola Gianotti, Elisabetta Carini, Alba Bigoloni, Giuseppe Tambussi, Silvia Nozza, Adriano Lazzarin, Antonella Castagna, Daniela Mancusi, Roberta Termini
Publikováno v:
PLoS ONE, Vol 13, Iss 2, p e0191300 (2018)
A regimen with rilpivirine (RPV), abacavir (ABC) and lamivudine (3TC) is simple and may allow the sparing of tenofovir and protease inhibitors. However, data on use of this combination as a strategy of switch are limited. Aims of the study were to as
Externí odkaz:
https://doaj.org/article/c4365025f47b44c08db6989c6e575ab2
Autor:
Andrea Antinori, Alessandra Vergori, Diego Ripamonti, Daniela Valenti, Vincenzo Esposito, Aurora Carleo, Stefano Rusconi, Antonio Cascio, Elio Manzillo, Massimo Andreoni, Giancarlo Orofino, Antonietta Cappuccio, Luigi Reale, Maria Giulia Marini, Daniela Mancusi, Roberta Termini, Alessia Uglietti, Marianna Portaro
Antiretroviral therapy (ART) significantly reduced Human Immunodeficiency Virus (HIV) morbidity and mortality; nevertheless, stigma still characterises the living with this condition. This study explored patients’ coping experience by integrating n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::48ef97359a9410300d3808df087d4742
https://doi.org/10.21203/rs.3.rs-2333625/v1
https://doi.org/10.21203/rs.3.rs-2333625/v1
Autor:
Martina Ranzenigo, Nicola Gianotti, Laura Galli, Andrea Poli, Andrea Mastrangelo, Elena Bruzzesi, Matteo Chiurlo, Silvia Nozza, Simona Bossolasco, Vincenzo Spagnuolo, Daniela Mancusi, Roberta Termini, Elisabetta Carini, Adriano Lazzarin, Antonella Castagna
Publikováno v:
Drug Design, Development and Therapy. 16:3737-3738
Ranzenigo M, Gianotti N, Galli L, et al. Drug Des Devel Ther. 2022;16:1975–1982. Page 1975, Abstract, Results, line five, the text “the ongoing regimen was based on NNRTIs in 37 (35%) and on InSTIs in 69 (65%)” should read “the ongoing regime
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca881ee922c30c9fe558f09187191d18
https://doi.org/10.2147/dddt.s394059
https://doi.org/10.2147/dddt.s394059
Autor:
Sergio Ferrara, Emanuele Focà, Barbara Menzaghi, Paolo Scerbo, Antonella Castagna, Andrea Antinori, Emanuele Pontali, Francesco Rucci, Giancarlo Orofino, Nicola Squillace, Lucia Aprea, Anna Maria Cattelan, Barbara Rossetti, Valentina Di Cristo, Roberta Termini, Daniela Valenti, Giordano Madeddu, Andrea Gori, Maria Vittoria Cossu, Maria E. Locatelli, Alessia Uglietti, Gabriella D’Ettore, Gaetana Sterrantino, Daniela Mancusi
Publikováno v:
The Patient
Objective: This prospective, multicenter, non-interventional cohort study enrolling human immunodeficiency virus (HIV)-1-infected, virally suppressed adult outpatients in Italy aimed to describe results obtained from patient-reported outcome question
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6076ccaada59cc85b71594dae06870d
https://doi.org/10.1007/s40271-020-00413-y
https://doi.org/10.1007/s40271-020-00413-y
Autor:
Alessandra Vergori, Elio Manzillo, Roberta Termini, Andrea Antinori, Diego Ripamonti, Antonella dʼArminio Monforte, Christof Stingone, Nicola Gianotti, Stefano Savinelli, Benedetto Maurizio Celesia, Francesco Castelli, Renato Maserati, Teresa Santantonio, Giancarlo Orofino, Barbara Menzaghi, Francesco Rucci, Maria Vittoria Cossu, Roberto Cauda, Gaetana Sterrantino, Anna Maria Cattelan, Alessia Uglietti, Andrea Gori, Stefano Rusconi, Daniela Mancusi, Stefano Bonora
Publikováno v:
Journal of Acquired Immune Deficiency Syndromes (1999)
Objective: This study investigates the effectiveness and tolerability of switching to a darunavir/cobicistat (DRV/c)-based antiretroviral regimen from a ritonavir-boosted protease inhibitor (PI/r)-based regimen in virologically suppressed HIV-positiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bdce8c5f26acdbf1b766237202f1d4dc
https://doi.org/10.1097/qai.0000000000002331
https://doi.org/10.1097/qai.0000000000002331
Publikováno v:
International Journal of Clinical Biostatistics and Biometrics. 7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a78ac3b56cbf848347b19083e57021bf
https://doi.org/10.23937/2469-5831/1510040
https://doi.org/10.23937/2469-5831/1510040
Autor:
Andrea Antinori, Teresa Bini, Stefano Rusconi, Nicola Gianotti, Daniela Mancusi, Roberta Termini
Publikováno v:
Drug Design, Development and Therapy. 13:1667-1685
Background: The protease inhibitor (PI) darunavir (DRV) has proven to be highly effective and well tolerated for HIV treatment. The DAD (Data collection on Adverse Effects of Anti-HIV Drugs) cohort showed an increased 5-year cumulative cardiovascular
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::55a29a3c529de37556020d7f10d871ec
https://doi.org/10.2147/dddt.s180981
https://doi.org/10.2147/dddt.s180981
Autor:
Barbara Menzaghi, Antonella Castagna, Giordano Madeddu, Maria Vittoria Cossu, Giancarlo Orofino, Roberta Termini, Francesco Rucci, Andrea Antinori, Anna Maria Cattelan, Nicola Squillace, Barbara Rossetti, Paolo Scerbo, Emanuele Focà, Sergio Ferrara, Gaetana Sterrantino, Daniela Mancusi, Daniela Valenti, Maria E. Locatelli, Andrea Gori, Emanuele Pontali, Alessia Uglietti, Gabriella D’Ettore, Valentina Di Cristo, Lucia Aprea
Publikováno v:
The Patient
Objective This prospective, multicenter, non-interventional cohort study enrolling human immunodeficiency virus (HIV)-1-infected, virally suppressed adult outpatients in Italy aimed to describe results obtained from patient-reported outcome questionn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c80524d268f8cab21fccdfd4c3c344e7
https://pubmed.ncbi.nlm.nih.gov/32266663
https://pubmed.ncbi.nlm.nih.gov/32266663
Autor:
Daniela Mancusi, Adriano Lazzarin, Nicola Gianotti, Nadia Galizzi, Roberta Termini, Silvia Nozza, Alba Bigoloni, Elisabetta Carini, Laura Galli, Antonella Castagna, Andrea Poli, Giuseppe Tambussi
Publikováno v:
PLoS ONE, Vol 13, Iss 2, p e0191300 (2018)
PLoS ONE
PLoS ONE
Introduction A regimen with rilpivirine (RPV), abacavir (ABC) and lamivudine (3TC) is simple and may allow the sparing of tenofovir and protease inhibitors. However, data on use of this combination as a strategy of switch are limited. Aims of the stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fed15fe14b51a51bf58944f2aa562b82
http://europepmc.org/articles/PMC5815573?pdf=render
http://europepmc.org/articles/PMC5815573?pdf=render
Autor:
Cristina Mussini, Alessia Uglietti, Roberta Termini, Daniela Mancusi, Antonella Castagna, Giulia Marchetti, Teresa Bini, Massimo Volpe, Rita Bellagamba
Cardiovascular disease is a leading cause of death in women, nevertheless it is often underestimated in female patients without overt risk factors. The chronic infection by Human Immunodeficiency Virus (HIV) is clearly associated, along with the use
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c311962290f31ec505c3b47e5ab56d7
http://hdl.handle.net/11573/946211
http://hdl.handle.net/11573/946211